Exercise for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different types of exercise can improve sleep and quality of life for people with Parkinson's disease. Participants will engage in cardiovascular training (CT), resistance training (RT), a combination of both known as multimodal training (MT), or join a control group with no new exercise routine. The goal is to determine if these exercises alleviate sleep problems, which are common in Parkinson's. Ideal candidates are those with Parkinson's who experience sleep difficulties and are not already participating in extensive exercise routines. As an unphased trial, this study provides a unique opportunity to contribute to understanding how exercise can enhance sleep and quality of life for those with Parkinson's.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you have been on a stable dosage of medication for the past month.
What prior data suggests that these exercise modalities are safe for individuals with Parkinson's disease?
Studies have shown that exercise is generally safe and beneficial for people with Parkinson's disease (PD). Research indicates that multimodal training (MT), which combines various exercises, effectively manages PD symptoms. It improves movement and quality of life without major safety concerns.
Cardiovascular training (CT), including activities like walking or cycling, is also safe for people with PD. This aerobic exercise can reduce the risk of heart disease and aid movement. Studies have not reported any major safety issues for this exercise in people with PD.
Resistance training (RT), involving lifting weights or using resistance bands, enhances muscle strength and movement in people with PD. Research shows that moderate-intensity resistance training is well-tolerated, with no major side effects reported.
Overall, these types of exercise are both safe and beneficial for people with Parkinson's.12345Why are researchers excited about this trial?
Researchers are excited about these exercise programs for Parkinson's disease because they offer a non-drug approach that could improve symptoms. Unlike medications that primarily aim to manage symptoms, these exercise routines—cardiovascular, resistance, and multimodal training—are designed to enhance physical function and possibly slow disease progression. Cardiovascular training focuses on heart health and endurance, resistance training builds muscle strength, and multimodal training combines both for a comprehensive workout. This holistic approach could offer a new avenue for managing Parkinson's, with the potential for fewer side effects compared to traditional drug treatments.
What evidence suggests that this trial's exercise treatments could be effective for Parkinson's disease?
Research has shown that different types of exercise can help people with Parkinson's disease (PD). In this trial, participants will follow various exercise regimens. Cardiovascular training (CT), which includes aerobic exercises like walking or cycling, improves balance, walking, and movement. Resistance training (RT), focusing on strength exercises, strengthens muscles and aids balance and walking. Multimodal training (MT), combining aerobic and strength exercises, enhances walking ability, movement, and strength. These exercises may also improve quality of life and address sleep issues, which often affect people with PD. Overall, these exercise methods offer promising benefits for managing PD symptoms.26789
Who Is on the Research Team?
Marc Roig, Ph.D.
Principal Investigator
McGill University
Are You a Good Fit for This Trial?
This trial is for people with mild to moderate Parkinson's Disease who have poor sleep quality. They must be on a stable medication dose and not have severe cognitive or mental health issues, untreated sleep apnea, osteoporosis, or other neurological conditions. They shouldn't already be very active or in another exercise/drug study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform either cardiovascular training, resistance training, multimodal training, or are allocated to a control condition for 12 weeks. Training is performed three times per week.
Follow-up
Participants are monitored for changes in sleep quality, cognitive function, and quality of life 8 weeks after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Cardiovascular training (CT)
- Multimodal training (MT)
- Resistance training (RT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
The Memory Lab
Collaborator
Jewish Rehabilitation Hospital
Collaborator
The Human Brain Control of Locomotion Lab (HBCL)
Collaborator
The Cummings Centre
Collaborator